Exact Sciences recently presented new data from a multi-cancer early detection biomarker validation study that showed the performance of four biomarkers found in the blood that can signal the presence of cancer in the body.
Category: Latest Research
New TGen research finds link in severity for Nonalcoholic Fatty Liver Disease
Nonalcoholic fatty liver disease (NAFLD) is both increasingly common and potentially deadly; yet its causes remain poorly understood. Now, a collaborative team of researchers at the Translational Genomics Research Institute (TGen), part of City of Hope, and Temple University has uncovered a link between decreases in an enzyme that makes choline in the liver —an essential nutrient for humans— and severity of NAFLD.
New ASU research shows critical link between breast cancer, diabetes
A new study from Dr. Dorothy Sears from Arizona State University’s College of Health Solutions reveals a critical link between breast cancer and diabetes in women.
Phoenix Veterans Affairs research team shows power of neoantigens in fighting cancer
New research from a Phoenix-led team at the Department of Veterans Affairs’ Dr. Karen Taraszka Hastings shows how powerful neoantigens can serve in the fight against cancer.
New technology from UArizona College of Medicine – Phoenix could expedite blood sample analysis
A new paper co-authored by the UArizona College of Medicine – Phoenix’s Dr. Frederic Zenhausern outlines a new technology that can expedite the analysis of human blood samples.
TGen, NAU study examines body’s antibody response to COVID-19 vaccine
Could the SARS-CoV-2 vaccine reawaken previous antibody responses and point the way to a universal coronavirus vaccine? A new analysis of the antibody response to a COVID-19 vaccine suggests the immune system’s past history with other coronaviruses, including those behind the common cold, shapes the patients response, according to a study published today in Cell Reports.
Study involving TGen, City of Hope uses DNA in the bloodstream to guide treatment for cancer patients
TGen and City of Hope investigators Kamel Lahouel and Cristian Tomasetti are working on study to help guide cancer treatment.
TGen study allows late-stage cancer patients to use their health data to guide care
A unique study pairing researchers from the Translational Genomics Research Institute (TGen), part of City of Hope, with one cancer patient is now underway to help answer that question. Rick Stanton, a former engineer and advanced prostate cancer patient, is at the center of TGen’s Patient Engagements, Operational Practices, and Laboratory Environment Standardization (PEOPLES) protocol.
TGen begins testing animals in captivity and nature for COVID-19
Working with state and federal wildlife agencies and private and public zoos across Arizona, the Translational Genomics Research Institute (TGen), part of City of Hope, is testing wild animals in captivity and in nature for SARS-CoV-2, the pathogen that causes COVID-19 in humans.
UArizona College of Medicine – Phoenix’s Ayman Fanous contributes to largest worldwide study of Schizophrenia
In a paper published April 8 in Nature, specific genes were identified that could play important roles in the psychiatric disorder. In the largest genetic study of schizophrenia, researchers including Ayman Fanous, MD, analyzed DNA from 76,755 people with schizophrenia and 243,649 without it to better understand the genes and biological processes underpinning the condition.